Workflow
鞋类零售
icon
Search documents
新余杰斯安鞋业有限公司成立 注册资本1万人民币
Sou Hu Cai Jing· 2025-11-06 05:11
Core Points - A new company, Xinyu Jiesan Footwear Co., Ltd., has been established with a registered capital of 10,000 RMB [1] - The legal representative of the company is Zhong Faxing [1] Business Scope - The company engages in a wide range of wholesale and retail activities, including footwear, clothing, and accessories [1] - It also sells various consumer goods such as home appliances, electronics, and sports equipment [1] - The company is involved in internet sales and retail of arts and crafts, jewelry, and toys, among other products [1]
沭阳县小弥胶鞋业经营部(个体工商户)成立 注册资本2万人民币
Sou Hu Cai Jing· 2025-11-05 01:20
Core Viewpoint - A new individual business named Shuyang Xiaomi Rubber Shoes Industry has been established, focusing on various retail and wholesale activities related to footwear and other consumer goods [1] Company Summary - The business is registered with a legal representative named Zhang Rui and has a registered capital of 20,000 RMB [1] - The operational scope includes retail and wholesale of shoes and hats, internet sales (excluding licensed goods), and various other consumer goods [1] Industry Summary - The company engages in a wide range of activities including the sale of textiles, clothing, household goods, labor protection products, daily necessities, hardware, and office supplies [1] - The business model allows for flexibility in operations, as it can conduct activities independently based on its business license [1]
新余领华鞋业有限公司成立 注册资本1万人民币
Sou Hu Cai Jing· 2025-10-24 02:48
Core Viewpoint - A new company, Xinyu Linghua Footwear Co., Ltd., has been established with a registered capital of 10,000 RMB, indicating a diversification into various retail and wholesale sectors, particularly in footwear and apparel [1] Company Summary - The legal representative of the newly established company is Wang Jingping [1] - The registered capital of the company is 10,000 RMB [1] - The business scope includes retail and wholesale of shoes, hats, and various consumer goods, indicating a broad market approach [1] Industry Summary - The company operates in multiple sectors including baby products, clothing, daily necessities, electronics, and sports equipment, reflecting a comprehensive strategy to capture diverse consumer needs [1] - The company is involved in both online and offline sales, which aligns with current retail trends emphasizing e-commerce [1] - The inclusion of second-hand goods and various specialty items like art and collectibles suggests a focus on sustainability and niche markets [1]
宝胜国际前9个月综合累计经营收益净额129.03亿元 同比下跌7.7%
Zhi Tong Cai Jing· 2025-10-13 08:46
Core Insights - The company reported a net operating revenue of 1.348 billion RMB for September 2025, a decrease of 4.8% compared to 1.417 billion RMB in September 2024 [1] - For the nine months ending September 30, 2025, the cumulative net operating revenue was 12.903 billion RMB, down 7.7% from 13.983 billion RMB in the same period of 2024 [1] Summary by Category - **Monthly Performance** - September 2025 net operating revenue: 1.348 billion RMB - September 2024 net operating revenue: 1.417 billion RMB - Year-over-year change: -4.8% [1] - **Cumulative Performance** - Nine months ending September 30, 2025 cumulative net operating revenue: 12.903 billion RMB - Nine months ending September 30, 2024 cumulative net operating revenue: 13.983 billion RMB - Year-over-year change: -7.7% [1]
TATA健康(01255.HK)发2024年度业绩:股东应占亏损6833.8万港元 同比扩大111.6%
Ge Long Hui· 2025-09-28 11:52
Core Insights - TATA Health (01255.HK) reported a revenue of HKD 124 million for the fiscal year ending December 31, 2024, representing a 40% year-on-year decline [1] - The company recorded a loss attributable to shareholders of HKD 68.34 million, which is an increase of 111.6% compared to the previous year [1] - Basic loss per share was HKD 0.28 [1] Revenue Analysis - The decline in revenue is primarily attributed to a decrease in the footwear business [1] - The challenging economic environment has led to weakened consumer sentiment, significantly impacting the retail sector in Hong Kong [1]
TATA健康(01255.HK)2025年中期业绩:股东应占溢利2059.6万港元
Ge Long Hui· 2025-09-28 11:52
Core Viewpoint - TATA Health (01255.HK) reported a significant decline in revenue for the six months ending June 30, 2025, primarily due to a decrease in footwear sales amid challenging retail conditions in Hong Kong [1] Financial Performance - Revenue for the period was HKD 42.118 million, representing a year-on-year decrease of 41.8% [1] - The company reported a profit attributable to owners of HKD 20.596 million, a turnaround from a loss of HKD 5.13 million in the same period last year [1] - Basic earnings per share were HKD 0.08 [1] Business Segment Analysis - The decline in revenue was mainly attributed to reduced sales in the footwear segment [1] - Consumer sentiment has been weak, and ongoing economic uncertainty has created a challenging environment for the retail sector in Hong Kong [1]
TATA健康(01255)发布2025年中期业绩,股东应占溢利2059.6万港元
智通财经网· 2025-09-28 11:10
Core Insights - TATA Health (01255) reported a revenue of HKD 42.118 million for the six months ending June 30, 2025, representing a year-on-year decline of 41.8% [1] - The company recorded a profit attributable to shareholders of HKD 20.596 million, compared to a loss of HKD 5.13 million in the same period last year [1] - Basic earnings per share were HKD 0.08 [1] Revenue Analysis - The decline in revenue was primarily attributed to a decrease in footwear business income [1] - The challenging environment for retail in Hong Kong was influenced by weak consumer sentiment and ongoing economic uncertainty [1]
TATA健康发布2025年中期业绩,股东应占溢利2059.6万港元
Zhi Tong Cai Jing· 2025-09-28 11:10
Core Insights - TATA Health (01255) reported a revenue of HKD 42.118 million for the six months ending June 30, 2025, representing a year-on-year decline of 41.8% [1] - The company achieved a profit attributable to shareholders of HKD 20.596 million, compared to a loss of HKD 5.13 million in the same period last year [1] - Basic earnings per share were HKD 0.08 [1] Revenue Analysis - The decline in revenue was primarily attributed to a decrease in footwear business income [1] - The challenging environment for retail in Hong Kong was influenced by weak consumer sentiment and ongoing economic uncertainty [1]
TATA健康(01255)发布2024年度业绩,股东应占亏损6833.8万港元,同比扩大111.6%
智通财经网· 2025-09-28 11:04
Group 1 - TATA Health (01255) reported an annual performance for the year ending December 31, 2024, with revenue of HKD 124 million, a decrease of 40% year-on-year [1] - The company recorded a loss attributable to shareholders of HKD 68.338 million, which represents a year-on-year increase of 111.6% [1] - Basic loss per share was HKD 0.28 [1] Group 2 - The decline in revenue compared to the fiscal year 2023 was primarily due to a decrease in footwear business revenue [1] - The reduction in footwear business earnings was mainly attributed to ongoing economic uncertainty, which has weakened consumer sentiment, creating a challenging environment for the retail sector in Hong Kong [1]
宝胜国际前8个月综合累计经营收益净额约115.55亿元,同比下跌8.1%
Zhi Tong Cai Jing· 2025-09-10 08:48
Group 1 - The company reported a net operating income of approximately 1.241 billion for September 2025, representing a year-on-year decline of 6.0% [1] - The cumulative net operating income for the first eight months was approximately 11.555 billion, showing a year-on-year decrease of 8.1% [1]